Doctor Andrew Manganaro is the Chief Medical Officer of the preventive healthcare center named Life Line Screening.
Many times, professionals in the healthcare area find that some patients that end up getting diagnosed with a disease or a health complication could have a much easier time treating it if they had known that they had that complication earlier. In other words, some diseases are progressive, and the sooner the patients find out about them, the better.
This is why preventive screening is becoming the treatment of the future. Not only does it allow for patients to preemptively check their health status just by going through fast and painless screenings, but it also allows for a direct monitoring of how the patient’s health is doing. Data is definitely better than wild guesses.
Diabetes, heart diseases, glucose levels, many diseases can be outright prevented just by being attended once in Life Line Screening.
Dr. Andrew Manganaro is one of the professionals responsible for this fantastic idea.
Born in Brooklyn, New York, Dr. Manganaro studied Philosophy and Biology and had his M.D. from the University of New York, School of Medicine. With more than thirty years of researching, developing and studying therapies, diseases, the human body, blood cells and the body’s responses to screenings, Dr. Andrew Manganaro developed new ways for medicine to tackle diseases.
Instead of treating them, prevent them. The idea for Life Line Screenings, according to Dr. Andrew Manganaro, came from his years as a cardiovascular surgeon, where he has treated many patients that came in with serious injuries that could be already in their homes if they knew the severe consequences of an aneurysm, for example. He saw countless lives go through life and death in ways that could have been easily avoided if there were easier ways to detect these issues.
With persistence, dedication, and patience, Dr. Andrew Manganaro surrounded himself with the best professionals in the area and is now one of the most promising personalities for the future of healthcare therapies.